KLTO — Klotho Neurosciences Balance Sheet
0.000.00%
- $4.98m
- $5.19m
Annual balance sheet for Klotho Neurosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | 0.005 | 0.341 | 0.173 | 0.064 |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 0.005 | 0.44 | 0.2 | 0.158 |
Net Intangible Assets | ||||
Long Term Investments | ||||
Total Assets | 0.005 | 118 | 19.5 | 2.46 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.009 | 0.506 | 2.31 | 1.25 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Total Other Liabilities | ||||
Total Liabilities | 0.009 | 4.93 | 8.24 | 1.27 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | -0.004 | 113 | 11.2 | 1.19 |
Total Liabilities & Shareholders' Equity | 0.005 | 118 | 19.5 | 2.46 |
Total Common Shares Outstanding |